Over 9.7 billion tenge allocated by Government for human papillomavirus vaccine procurement

The Government has allocated funds from the reserve for the purchase of vaccine against human papillomavirus (HPV), which will allow the introduction of appropriate vaccination in Kazakhstan. The decree was signed by Prime Minister Olzhas Bektenov, El.kz cites primeminister.kz.

Funds in the amount of more than 9.7 billion tenge will be transferred to the budgets of regions, cities of republican significance and the capital in the form of targeted current transfers for the purchase of more than 351 thousand doses of vaccine. 

Cervical cancer (CRC), caused by the human papilloma virus, is one of the most common types of cancer in the world accounting for up to 13.1% of all cases. About 300,000 women die from it every year. In Kazakhstan, HCV ranks second in prevalence among other types of cancer in women of all ages. Every year about 1,900 new cases are registered in the country, and more than 600 women die from this pathology.

The only method to combat HPV and the development of cancer is vaccination. In accordance with the National Vaccination Calendar of the Republic of Kazakhstan and taking into account the WHO recommendation, HPV vaccination will be administered to girls 11 years old twice with an interval of 6 months. At the same time, Kazakhstan will use a quadrivalent vaccine, which protects against the most oncogenic types of HPV (6, 11, 16, 18).

Subscribe to our Telegram channel and be the first to know the news!